Cool Upward Move for Cesca Therapeutics (KOOL); Teva Pharma (TEVA) Seal Half-Billion Dollar Deal for Allergan’s (AGN) Anda
Cesca Therapeutics Inc. (Nasdaq:KOOL) shares skyrocketed over 35% in premarket trade Wednesday as the company released promising 40-month follow-up results from a feasibility study in patients with late stage critical limb ischemia using its SurgWerks(TM) system
KOOL stock closed in negative territory by 0.45% (or -$0.02) at $4.45 with a total voulme of 343,417 shares traded on Tuesday
Cesca Therapeutics, which is engaged in the research, development, and commercialization of cell-based therapeutics for use in regenerative medicine, has 13.39M Shares Outstanding, Market Capitalization (intraday) of $13.39M and KOOL stock 52-week range is between $1.64 and $14.83 per share
Israel-based Teva Pharmaceutical Industries Ltd. (NYSE:TEVA) said before the opening bell on Wednesday that it has reached a deal to acquire Allergan plc‘s (NYSE:AGN) Anda Inc. distribution business for $500 million.
TEVA stock finished at $52.96, down $0.65 (or -1.21%) and 5,416,084 of its shares changed hands on Tuesday’s trading session
Teva Pharmaceutical, which develops, manufactures, markets, and distributes generic medicines and a portfolio of specialty medicines worldwide, has 1.02B Shares Outstanding, Market Capitalization (intraday) of $53.06B and TEVA stock one-year range is from $48.01 to $71.68 per share
Disclaimer: The disclaimer is to be read and fully understood before using our site, or joining our email list. GalaxyStocks is not a registered investment adviser. This material is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. Investors should always conduct their own due diligence with any potential investment, with independent research and other professional advice. Read full disclaimer at http://galaxystocks.com/disclaimer/